# Localized Therapeutics for the Treatment of Gastrointestinal Disorders II

> **NCT02745678** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 3 (actual)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **DRUG:** Thermosensitive gel rectal formulation

## Key facts

- **NCT ID:** NCT02745678
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2018-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02745678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02745678, "Localized Therapeutics for the Treatment of Gastrointestinal Disorders II". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02745678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*